Cargando…
Trisubstituted 1,3,5-Triazines: The First Ligands of the sY12-Binding Pocket on Chemokine CXCL12
[Image: see text] CXCL12, a CXC-type chemokine, binds its receptor CXCR4, and the resulting signaling cascade is essential during development and subsequently in immune function. Pathologically, the CXCL12–CXCR4 signaling axis is involved in many cancers and inflammatory diseases and thus has sparke...
Autores principales: | Sprague, Daniel J., Getschman, Anthony E., Fenske, Tyler G., Volkman, Brian F., Smith, Brian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592115/ https://www.ncbi.nlm.nih.gov/pubmed/34795867 http://dx.doi.org/10.1021/acsmedchemlett.1c00388 |
Ejemplares similares
-
Structural Analysis of a Novel
Small Molecule Ligand
Bound to the CXCL12 Chemokine
por: Smith, Emmanuel W., et al.
Publicado: (2014) -
A new obligate CXCL4–CXCL12 heterodimer for studying chemokine heterodimer activities and mechanisms
por: Nguyen, Khanh T.P., et al.
Publicado: (2022) -
Design and Synthesis of New 1,3,5‐Trisubstituted Triazines for the Treatment of Cancer and Inflammation
por: Zacharie, Boulos, et al.
Publicado: (2018) -
Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017) -
Trisubstituted 1,3,5-Triazines as Histamine H(4) Receptor Antagonists with Promising Activity In Vivo
por: Olejarz-Maciej, Agnieszka, et al.
Publicado: (2023)